Expert Panel Issues Guidance on Rituximab and COVID-19 Vaccination

Expert Panel Issues Guidance on Rituximab and COVID-19 Vaccination

294561

Expert Panel Issues Guidance on Rituximab and COVID-19 Vaccination

A group of European experts have drafted a series of recommendations for the use of immunosuppressive therapies, such as rituximab, and the timing for COVID-19 vaccination in people with ANCA-associated vasculitis (AAV). Most treatment plans will require a tailored approach, and a likely delay in immunosuppressive doses during vaccination, the panel advised. The report, “COVID-19 and ANCA-associated vasculitis — recommendations for vaccine preparedness and the use of rituximab,” was published in the journal Nephrology Dialysis Transplantation.…

You must be logged in to read/download the full post.